SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-114996
Filing Date
2023-11-07
Accepted
2023-11-07 07:05:27
Documents
14
Period of Report
2023-11-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2329850d1_8k.htm   iXBRL 8-K 24831
2 EXHIBIT 99.1 tm2329850d1_ex99-1.htm EX-99.1 137887
6 GRAPHIC tm2329850d1_ex99-1img002.jpg GRAPHIC 11030
  Complete submission text file 0001104659-23-114996.txt   370850

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA rytm-20231107.xsd EX-101.SCH 3015
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE rytm-20231107_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rytm-20231107_pre.xml EX-101.PRE 22359
8 EXTRACTED XBRL INSTANCE DOCUMENT tm2329850d1_8k_htm.xml XML 3320
Mailing Address 222 BERKELEY STREET 12TH FLOOR BOSTON MA 02116
Business Address 222 BERKELEY STREET 12TH FLOOR BOSTON MA 02116 857-264-4280
RHYTHM PHARMACEUTICALS, INC. (Filer) CIK: 0001649904 (see all company filings)

IRS No.: 462159271 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38223 | Film No.: 231381515
SIC: 2834 Pharmaceutical Preparations